The Impact of COVID-19 on Substance Use and Related Consequences among Patients in Office-Based Opioid Use Disorder Treatment.
Weinstein ZM, Magane KM, Lodi S, Ventura AS, Bazzi AR, Blodgett J, Fielman S, Davoust M, Shea MG, Chen CA, Cheng A, Theisen J, Blakemore S, Saitz R.
Weinstein ZM, et al. Among authors: magane km.
J Addict Med. 2024 Aug 5. doi: 10.1097/ADM.0000000000001367. Online ahead of print.
J Addict Med. 2024.
PMID: 39101572